InfuSystem Holdings (INFU) Asset Writedowns and Impairment (2010 - 2026)
InfuSystem Holdings' (INFU) quarterly Asset Writedowns and Impairment came in at $202000.0 in Q1 2026, down 21.4% YoY from $257000.0 in Q1 2025, and down 51.56% on a QoQ basis from $417000.0 in Q4 2025.
InfuSystem Holdings (INFU) Asset Writedowns and Impairment (2010 - 2026) Analysis & Trends
InfuSystem Holdings (INFU) has 11 years of Asset Writedowns and Impairment data on file, last reported at $202000.0 in Q1 2026.
- Quarterly Asset Writedowns and Impairment fell 21.4% year-over-year to $202000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $464000.0 (up 110.91% YoY) and the FY2025 annual result came in at $519000.0, up 410.78% from the prior year.
- Asset Writedowns and Impairment retreated to $202000.0 in Q1 2026, from $417000.0 in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $450000.0 in Q1 2023 to a low of -$845000.0 in Q4 2024.
- A 5-year average of $90058.8 and a median of $171000.0 in 2022 frame the typical range for Asset Writedowns and Impairment.
- Annual changes were most pronounced in 2022 — Asset Writedowns and Impairment tumbled 1000.0% — and 2024, when it surged 765.67%.
- Tracing INFU's Asset Writedowns and Impairment over 5 years: stood at $171000.0 in 2022, then soared by 161.99% to $448000.0 in 2023, then tumbled by 288.62% to -$845000.0 in 2024, then surged by 149.35% to $417000.0 in 2025, then sank by 51.56% to $202000.0 in 2026.
- The last three Asset Writedowns and Impairment figures came in at $202000.0 (Q1 2026), $417000.0 (Q4 2025), and $63000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | InfuSystem Holdings | 244.87 Mn | 243.90 Mn | 21.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 300,000.00 |
| Jun 30, 2026 | 300,000.00 |
| Mar 31, 2026 | 202,000.00 |
| Mar 31, 2026 | 202,000.00 |
| Dec 31, 2025 | 417,000.00 |
| Dec 31, 2025 | 417,000.00 |
| Sep 30, 2025 | 63,000.00 |
| Sep 30, 2025 | 63,000.00 |
| Jun 30, 2025 | -218,000.00 |
| Jun 30, 2025 | -218,000.00 |
| Mar 31, 2025 | 257,000.00 |
| Mar 31, 2025 | 257,000.00 |
| Dec 31, 2024 | -845,000.00 |
| Dec 31, 2024 | -845,000.00 |
| Sep 30, 2024 | 362,000.00 |
| Sep 30, 2024 | 362,000.00 |
| Jun 30, 2024 | 446,000.00 |
| Jun 30, 2024 | 446,000.00 |
| Mar 31, 2024 | -130,000.00 |
| Mar 31, 2024 | -130,000.00 |